NCT00313339View on ClinicalTrials.gov

Intra-coronary Infusion of Bone Marrow Derived Autologous CD34+ Selected Cells in Patients With Acute Myocardial Infarction

PHASE1CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2013

Conditions
Myocardial InfarctionCoronary Artery Disease
Interventions
DRUG

Intra-coronary infusion

In our study there will be four dosing cohorts (5, 10, 20 and 30 x 106) of CD34+ cells.

Trial Locations (1)

30326

Emory University, Atlanta

All Listed Sponsors
collaborator

Texas Heart Institute

OTHER

lead

Emory University

OTHER

NCT00313339 - Intra-coronary Infusion of Bone Marrow Derived Autologous CD34+ Selected Cells in Patients With Acute Myocardial Infarction | Biotech Hunter | Biotech Hunter